In the study, we discovered that CDK9 inhibitors induced the apoptosis of B-ALL cells by restraining glycolysis, which was enhanced by co-treatment with glycolysis inhibitors in vitro. Here, CDK9 is linked to acute lymphoblastic leukemia.